stockrow
Friday 6 November 2026
Export USNA’s income statement to Excel — free account
USANA Health Sciences, Inc.
USNA Consumer Defensive Packaged Foods
USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024.
- Revenue
- −3.64%
- EPS
- −3.47%
- Free cash flow
- +180.6%
Quarter to September 2026, against a year earlier
13.58
0.28
−2.02%
Follow USNA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 6 | 5 | — |
| 2.02% | 1.65% | (4.19%) | 0.00% | ||
| 1.44% | 1.19% | (3.08%) | (2.95%) | ||
ROIC |
6.24% | 5.85% | (0.19%) | (0.67%) | |
Return on Tangible Assets |
4.23% | 3.27% | (8.22%) | (7.78%) | |
Average Days of Receivables |
1.69 | 3.81 | 1.33 | 2.03 | |
Free Cash Flow per Share |
0.67 | 0.38 | 1.08 | 0.00 | |
Free Cash Flow |
12.43 | 6.91 | 19.90 | — | |
Capital Expenditures |
(9.92) | (9.71) | (7.82) | — | |
| Other line items | |||||
Cash ROIC |
1.80% | 0.98% | 2.86% | 0.00% | |
Accounts Receivable Turnover |
141.83 | 108.44 | 173.97 | 147.98 | |
Accounts Payable Turnover |
13.73 | 13.76 | 12.36 | 12.15 | |
Inventory Turnover |
2.33 | 2.45 | 2.43 | 2.36 | |
Average Days of Payables |
31.37 | 28.50 | 27.34 | 31.31 | |
Days of Inventory on Hand |
186.47 | 169.22 | 152.99 | 149.05 | |
Tax Rate |
(0.72) | (0.77) | (12.53) | 474.44 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
73.49% | 72.95% | 73.61% | 73.69% | |
Share Based Compensation of Revenue |
1.49% | 1.56% | 1.55% | 0.00% | |
Interest Coverage |
44.46 | 53.11 | — | (8.34) | |
Operating CF/Net income |
2.08 | 1.87 | (1.25) | 0.00 | |
Depreciation/Fixed assets |
0.42 | 0.41 | 0.72 | 0.00 | |
Capex/Depreciation |
(0.25) | (0.25) | (0.12) | — | |
Revenue per Share |
49.92 | 50.33 | 49.41 | 48.96 | |
Operating CF per Share |
1.21 | 0.90 | 1.50 | 0.00 | |
Capex per Share |
(0.54) | (0.53) | (0.42) | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026